Spyglass Pharma, Inc.
Clinical trials sponsored by Spyglass Pharma, Inc., explained in plain language.
-
Tiny implant could replace daily eye drops for glaucoma
Disease control Recruiting nowThis study is testing if a tiny, slow-release implant placed in the eye during cataract surgery works as well as daily eye drops to lower eye pressure in people with mild to moderate glaucoma. About 400 people who need cataract surgery and have glaucoma will be randomly assigned …
Phase: PHASE3 • Sponsor: SpyGlass Pharma, Inc. • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC
-
Tiny implant could free glaucoma patients from daily eye drops
Disease control Recruiting nowThis study is testing a small, slow-release implant placed in the eye during routine cataract surgery. It aims to lower eye pressure in people with mild to moderate glaucoma or high eye pressure. The implant is being compared to standard daily eye drops to see if it is as safe an…
Phase: PHASE3 • Sponsor: SpyGlass Pharma, Inc. • Aim: Disease control
Last updated Mar 30, 2026 14:29 UTC